Impact of Telemedicine Expansion on Healthcare Utilization and Spending

Recent research from UCLA, published in JAMA Network Open, reveals that the expansion of telemedicine during the COVID-19 pandemic did not significantly alter the volume of medical visits or healthcare spending across different insurance payers. This study dispels concerns that telehealth might escalate healthcare utilization and costs, highlighting its potential as an efficient healthcare delivery method.

In 2020, the Centers for Medicare & Medicaid Services (CMS) enacted pivotal telemedicine policy changes. These included payment parity with in-person visits, geographic restriction removals, and the elimination of out-of-pocket costs. Although initially temporary measures during the pandemic, lawmakers have extended these policies to further gauge telehealth's impact on healthcare use and financial landscapes. Current discussions focus on their future as the expiry approaches in 2027.

Dr. John N. Mafi, lead researcher from UCLA’s David Geffen School of Medicine, remarked, “Our findings suggest neither prediction came true on a national scale. As telemedicine use grew, visits and spending in heavy users tracked closely with patterns in lighter users.” This underscores telemedicine’s role as a viable alternative to in-person care without boosting overall healthcare usage.

The study analyzed medical claims data from over three million U.S. adults covered by diverse insurance plans, including Medicare, Medicaid, and commercial insurance. Results indicated a slight decrease of 2.4% in telemedicine visits and a 0.5% reduction in spending, though these were not statistically significant, implying potential random variation.

Subgroup analysis showed no substantial shifts in spending or visits across urban and rural populations or among Medicaid, Medicare Advantage, and commercial insurance holders. While numerical differences emerged within specific groups, they lacked statistical significance.

Dr. Katherine Kahn, co-author and professor at UCLA, highlighted the preliminary nature of these findings, stating, “Our analysis runs only through late 2023, when telemedicine use was still settling into a new equilibrium. Much more work is needed to understand telemedicine’s longer-term effects.”

Further research is essential to evaluate telemedicine's enduring impact on healthcare quality, outcomes, and expenditures across diverse populations. Policymakers are encouraged to closely monitor these developments as more evidence emerges. This research was funded by Arnold Ventures, the National Institutes of Health, and a National Institute on Aging award.